CVE-2026-21974

5.3 MEDIUM
Published: January 20, 2026 Modified: January 29, 2026
View on NVD

Description

Vulnerability in the Oracle Life Sciences Central Designer product of Oracle Health Sciences Applications (component: Platform). The supported version that is affected is 7.0.1.0. Easily exploitable vulnerability allows unauthenticated attacker with network access via HTTP to compromise Oracle Life Sciences Central Designer. Successful attacks of this vulnerability can result in unauthorized read access to a subset of Oracle Life Sciences Central Designer accessible data. CVSS 3.1 Base Score 5.3 (Confidentiality impacts). CVSS Vector: (CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:L/I:N/A:N).

AI Explanation

Get an AI-powered plain-language explanation of this vulnerability and remediation steps.

Login to generate AI explanation

CVSS v3.x Details

0.0 Low Medium High Critical 10.0
Vector String
CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:L/I:N/A:N

References to Advisories, Solutions, and Tools

Patch Vendor Advisory Exploit Third Party Advisory
https://www.oracle.com/security-alerts/cpujan2026.html
Source: secalert_us@oracle.com
Vendor Advisory

1 reference(s) from NVD

Quick Stats

CVSS v3 Score
5.3 / 10.0
EPSS (Exploit Probability)
0.0%
11th percentile
Exploitation Status
Not in CISA KEV

Weaknesses (CWE)

Affected Vendors

oracle